{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T23:39:31Z","timestamp":1775173171346,"version":"3.50.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Merck Sharp & Dohme LLC"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s11136-024-03840-8","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T09:45:41Z","timestamp":1735897541000},"page":"809-821","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Health state utilities associated with invasive pneumococcal disease, pneumonia, and recurrent acute otitis media in young children"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6374-5948","authenticated-orcid":false,"given":"Louis S.","family":"Matza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy A.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Chun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucinda","family":"Hetherington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Rowen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"Feemster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bayad","family":"Nozad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew S.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Hoberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salini","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"key":"3840_CR1","unstructured":"Centers for Disease Control and Prevention. (2022). Streptococcus pneumoniae. Retrieved from https:\/\/www.cdc.gov\/pneumococcal\/clinicians\/streptococcus-pneumoniae.html#:~:text=There%20are%20100%20known%20serotypes,more%20than%20100%20known%20serotypes"},{"key":"3840_CR2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12879-016-1648-2","volume":"16","author":"E Backhaus","year":"2016","unstructured":"Backhaus, E., Berg, S., Andersson, R., Ockborn, G., Malmstrom, P., Dahl, M., Nasic, S., & Trollfors, B. (2016). Epidemiology of invasive pneumococcal infections: Manifestations, incidence and case fatality rate correlated to age, gender and risk factors. BMC Infectious Diseases, 16, 367. https:\/\/doi.org\/10.1186\/s12879-016-1648-2","journal-title":"BMC Infectious Diseases"},{"issue":"6","key":"3840_CR3","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1513\/AnnalsATS.201511-778FR","volume":"13","author":"AC Berical","year":"2016","unstructured":"Berical, A. C., Harris, D., Dela Cruz, C. S., & Possick, J. D. (2016). Pneumococcal vaccination strategies. An update and perspective. Annals of the American Thoracic Society, 13(6), 933\u2013944. https:\/\/doi.org\/10.1513\/AnnalsATS.201511-778FR","journal-title":"Annals of the American Thoracic Society"},{"issue":"1","key":"3840_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/21645515.2017.1371378","volume":"14","author":"M Ceyhan","year":"2018","unstructured":"Ceyhan, M., Ozsurekci, Y., Aykac, K., Hacibedel, B., & Ozbilgili, E. (2018). Economic burden of pneumococcal infections in children under 5 years of age. Human Vaccines & Immunotherapeutics, 14(1), 106\u2013110. https:\/\/doi.org\/10.1080\/21645515.2017.1371378","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"10253","key":"3840_CR5","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(20)31550-6","volume":"396","author":"FM de Benedictis","year":"2020","unstructured":"de Benedictis, F. M., Kerem, E., Chang, A. B., Colin, A. A., Zar, H. J., & Bush, A. (2020). Complicated pneumonia in children. Lancet, 396(10253), 786\u2013798. https:\/\/doi.org\/10.1016\/S0140-6736(20)31550-6","journal-title":"Lancet"},{"issue":"14","key":"3840_CR6","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1001\/jama.295.14.1668","volume":"295","author":"KA Poehling","year":"2006","unstructured":"Poehling, K. A., Talbot, T. R., Griffin, M. R., Craig, A. S., Whitney, C. G., Zell, E., Lexau, C. A., Thomas, A. R., Harrison, L. H., Reingold, A. L., Hadler, J. L., Farley, M. M., Anderson, B. J., & Schaffner, W. (2006). Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA, 295(14), 1668\u20131674. https:\/\/doi.org\/10.1001\/jama.295.14.1668","journal-title":"JAMA"},{"issue":"5","key":"3840_CR7","doi-asserted-by":"publisher","first-page":"e14913","DOI":"10.7759\/cureus.14913","volume":"13","author":"V Thadchanamoorthy","year":"2021","unstructured":"Thadchanamoorthy, V., & Dayasiri, K. (2021). Review on pneumococcal infection in children. Cureus, 13(5), e14913. https:\/\/doi.org\/10.7759\/cureus.14913","journal-title":"Cureus"},{"issue":"1","key":"3840_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12916-018-1004-z","volume":"16","author":"D Thorrington","year":"2018","unstructured":"Thorrington, D., Andrews, N., Stowe, J., Miller, E., & van Hoek, A. J. (2018). Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control. BMC Medicine, 16(1), 13. https:\/\/doi.org\/10.1186\/s12916-018-1004-z","journal-title":"BMC Medicine"},{"issue":"2","key":"3840_CR9","doi-asserted-by":"publisher","first-page":"e0192640","DOI":"10.1371\/journal.pone.0192640","volume":"13","author":"D Thorrington","year":"2018","unstructured":"Thorrington, D., van Rossum, L., Knol, M., de Melker, H., Rumke, H., Hak, E., & van Hoek, A. J. (2018). Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands. PLoS ONE, 13(2), e0192640. https:\/\/doi.org\/10.1371\/journal.pone.0192640","journal-title":"PLoS ONE"},{"key":"3840_CR10","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7239a5","author":"Advisory Committee on Immunization Practices","year":"2023","unstructured":"Advisory Committee on Immunization Practices. (2023). AACIP updates: Recommendations for use of 20-valent pneumococcal conjugate vaccine in children - United States, 2023. MMWR. Morbidity and Mortality Weekly Report. https:\/\/doi.org\/10.15585\/mmwr.mm7239a5","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"3840_CR11","unstructured":"European Medicines Agency. (2024). Vaxneuvance - pneumococcal polysaccharide conjugate vaccine (adsorbed). Retrieved from https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/vaxneuvance"},{"issue":"4","key":"3840_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.15585\/mmwr.mm7104a1","volume":"71","author":"M Kobayashi","year":"2022","unstructured":"Kobayashi, M., Farrar, J. L., Gierke, R., Britton, A., Childs, L., Leidner, A. J., Campos-Outcalt, D., Morgan, R. L., Long, S. S., Talbot, H. K., Poehling, K. A., & Pilishvili, T. (2022). Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: Updated recommendations of the advisory committee on immunization practices - United States, 2022. MMWR Morbidity and Mortality Weekly Report, 71(4), 109\u2013117. https:\/\/doi.org\/10.15585\/mmwr.mm7104a1","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"3840_CR13","volume-title":"Measuring and valuing health benefits for economic evaluation","author":"J Brazier","year":"2017","unstructured":"Brazier, J., Ratcliffe, J., Saloman, J., & Tsuchiya, A. (2017). Measuring and valuing health benefits for economic evaluation (2nd ed.). Oxford University Press.","edition":"2"},{"issue":"2","key":"3840_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s11136-021-02941-y","volume":"31","author":"R O\u2019Reilly","year":"2022","unstructured":"O\u2019Reilly, R., Yokoyama, S., Boyle, J., Kwong, J. C., McGeer, A., To, T., & Sander, B. (2022). The impact of acute pneumococcal disease on health state utility values: A systematic review. Quality of Life Research, 31(2), 375\u2013388. https:\/\/doi.org\/10.1007\/s11136-021-02941-y","journal-title":"Quality of Life Research"},{"issue":"2","key":"3840_CR15","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1093\/pubmed\/fdab159","volume":"44","author":"Z Tang","year":"2022","unstructured":"Tang, Z., Matanock, A., Jeon, S., & Leidner, A. J. (2022). A review of health-related quality of life associated with pneumococcal disease: Pooled estimates by age and type of disease. Journal of Public Health (Oxford, England), 44(2), e234\u2013e240. https:\/\/doi.org\/10.1093\/pubmed\/fdab159","journal-title":"Journal of Public Health (Oxford, England)"},{"issue":"1","key":"3840_CR16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/s0149-2918(96)80188-3","volume":"18","author":"PI Oh","year":"1996","unstructured":"Oh, P. I., Maerov, P., Pritchard, D., Knowles, S. R., Einarson, T. R., & Shear, N. H. (1996). A cost-utility analysis of second-line antibiotics in the treatment of acute otitis media in children. Clinical Therapeutics, 18(1), 160\u2013182. https:\/\/doi.org\/10.1016\/s0149-2918(96)80188-3","journal-title":"Clinical Therapeutics"},{"key":"3840_CR17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/1471-2431-13-122","volume":"13","author":"W Kulpeng","year":"2013","unstructured":"Kulpeng, W., Sornsrivichai, V., Chongsuvivatwong, V., Rattanavipapong, W., Leelahavarong, P., Cairns, J., Lubell, Y., & Teerawattananon, Y. (2013). Variation of health-related quality of life assessed by caregivers and patients affected by severe childhood infections. BMC Pediatrics, 13, 122. https:\/\/doi.org\/10.1186\/1471-2431-13-122","journal-title":"BMC Pediatrics"},{"issue":"5","key":"3840_CR18","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1524-4733.2010.00711.x","volume":"13","author":"S Petrou","year":"2010","unstructured":"Petrou, S., Dakin, H., Abangma, G., Benge, S., & Williamson, I. (2010). Cost-utility analysis of topical intranasal steroids for otitis media with effusion based on evidence from the GNOME trial. Value in Health, 13(5), 543\u2013551. https:\/\/doi.org\/10.1111\/j.1524-4733.2010.00711.x","journal-title":"Value in Health"},{"issue":"1","key":"3840_CR19","first-page":"43","volume":"154","author":"JE Bennett","year":"2000","unstructured":"Bennett, J. E., Sumner, W., 2nd., Downs, S. M., & Jaffe, D. M. (2000). Parents\u2019 utilities for outcomes of occult bacteremia. Archives of Pediatrics & Adolescent Medicine, 154(1), 43\u201348.","journal-title":"Archives of Pediatrics & Adolescent Medicine"},{"issue":"1","key":"3840_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40801-016-0099-9","volume":"4","author":"B Crawford","year":"2017","unstructured":"Crawford, B., Hashim, S. S., Prepageran, N., See, G. B., Meier, G., Wada, K., Coon, C., Delgleize, E., & DeRosa, M. (2017). Impact of pediatric acute otitis media on child and parental quality of life and associated productivity loss in Malaysia: A prospective observational study. Drugs Real World Outcomes, 4(1), 21\u201331. https:\/\/doi.org\/10.1007\/s40801-016-0099-9","journal-title":"Drugs Real World Outcomes"},{"issue":"1","key":"3840_CR21","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s41687-020-00251-4","volume":"4","author":"J Verstraete","year":"2020","unstructured":"Verstraete, J., Ramma, L., & Jelsma, J. (2020). Validity and reliability testing of the Toddler and Infant (TANDI) health related quality of life instrument for very young children. Journal of Patient-Reported Outcomes, 4(1), 94. https:\/\/doi.org\/10.1186\/s41687-020-00251-4","journal-title":"Journal of Patient-Reported Outcomes"},{"issue":"2","key":"3840_CR22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jval.2022.07.015","volume":"26","author":"W Furlong","year":"2023","unstructured":"Furlong, W., Rae, C., Feeny, D., Ghotra, S., Breakey, V. R., Carter, T., Pai, N., Pullenayegum, E., Xie, F., & Barr, R. (2023). Generic health-related quality of life utility measure for preschool children (health utilities preschool): Design, development, and properties. Value in Health, 26(2), 251\u2013260. https:\/\/doi.org\/10.1016\/j.jval.2022.07.015","journal-title":"Value in Health"},{"issue":"6","key":"3840_CR23","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.jval.2020.12.017","volume":"24","author":"LS Matza","year":"2021","unstructured":"Matza, L. S., Stewart, K. D., Lloyd, A. J., Rowen, D., & Brazier, J. E. (2021). Vignette-based utilities: Usefulness, limitations, and methodological recommendations. Value in Health, 24(6), 812\u2013821. https:\/\/doi.org\/10.1016\/j.jval.2020.12.017","journal-title":"Value in Health"},{"issue":"3","key":"3840_CR24","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1586\/14737167.2014.912562","volume":"14","author":"KS Boye","year":"2014","unstructured":"Boye, K. S., Matza, L. S., Feeny, D. H., Johnston, J. A., Bowman, L., & Jordan, J. B. (2014). Challenges to time trade-off utility assessment methods: When should you consider alternative approaches? Expert Review of Pharmacoeconomics & Outcomes Research, 14(3), 437\u2013450. https:\/\/doi.org\/10.1586\/14737167.2014.912562","journal-title":"Expert Review of Pharmacoeconomics & Outcomes Research"},{"issue":"6","key":"3840_CR25","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s10198-019-01036-3","volume":"20","author":"LS Matza","year":"2019","unstructured":"Matza, L. S., Kim, K. J., Yu, H., Belden, K. A., Chen, A. F., Kurd, M., Lee, B. Y., & Webb, J. (2019). Health state utilities associated with post-surgical Staphylococcus aureus infections. The European Journal of Health Economics, 20(6), 819\u2013827. https:\/\/doi.org\/10.1007\/s10198-019-01036-3","journal-title":"The European Journal of Health Economics"},{"issue":"1","key":"3840_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12955-022-01998-8","volume":"20","author":"N Devlin","year":"2022","unstructured":"Devlin, N., Pan, T., Kreimeier, S., Verstraete, J., Stolk, E., Rand, K., & Herdman, M. (2022). Valuing EQ-5D-Y: The current state of play. Health and Quality of Life Outcomes, 20(1), 105. https:\/\/doi.org\/10.1186\/s12955-022-01998-8","journal-title":"Health and Quality of Life Outcomes"},{"issue":"11","key":"3840_CR27","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.jval.2018.05.002","volume":"21","author":"S Kreimeier","year":"2018","unstructured":"Kreimeier, S., Oppe, M., Ramos-Goni, J. M., Cole, A., Devlin, N., Herdman, M., Mulhern, B., Shah, K. K., Stolk, E., Rivero-Arias, O., & Greiner, W. (2018). Valuation of EuroQol five-dimensional questionnaire, youth version (EQ-5D-Y) and EuroQol five-dimensional questionnaire, three-level version (EQ-5D-3L) health states: The impact of wording and perspective. Value in Health, 21(11), 1291\u20131298. https:\/\/doi.org\/10.1016\/j.jval.2018.05.002","journal-title":"Value in Health"},{"issue":"4","key":"3840_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s40273-021-01128-0","volume":"40","author":"J Kwon","year":"2022","unstructured":"Kwon, J., Freijser, L., Huynh, E., Howell, M., Chen, G., Khan, K., Daher, S., Roberts, N., Harrison, C., Smith, S., Devlin, N., Howard, K., Lancsar, E., Bailey, C., Craig, J., Dalziel, K., Hayes, A., Mulhern, B., Wong, G., Ratcliffe,  J., & Petrou, S. (2022). Systematic review of conceptual, age, measurement and valuation considerations for generic multidimensional childhood patient-reported outcome measures. Pharmacoeconomics, 40(4), 379\u2013431. https:\/\/doi.org\/10.1007\/s40273-021-01128-0","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"3840_CR29","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2165\/00019053-200725090-00001","volume":"25","author":"LA Prosser","year":"2007","unstructured":"Prosser, L. A., Hammitt, J. K., & Keren, R. (2007). Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children: Theoretical and methodological considerations. PharmacoEconomics, 25(9), 713\u2013726. https:\/\/doi.org\/10.2165\/00019053-200725090-00001","journal-title":"PharmacoEconomics"},{"key":"3840_CR30","unstructured":"Rowen, D., Devlin, N., Matza, L. S., & Stolk, E. (2023). ISPOR Good Practice Task Force Recommendations on Valuing HRQoL of Children & Adolescents in Economic Evaluation Open Meeting (Pediatric Utilities). Paper presented at the ISPOR EU, Copenhagen, Denmark."},{"issue":"4","key":"3840_CR31","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s40273-019-00873-7","volume":"38","author":"D Rowen","year":"2020","unstructured":"Rowen, D., Rivero-Arias, O., Devlin, N., & Ratcliffe, J. (2020). Review of valuation methods of preference-based measures of health for economic evaluation in child and adolescent populations: Where are we now and where are we going? PharmacoEconomics, 38(4), 325\u2013340. https:\/\/doi.org\/10.1007\/s40273-019-00873-7","journal-title":"PharmacoEconomics"},{"issue":"Suppl 2","key":"3840_CR32","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s40273-022-01206-x","volume":"40","author":"S Kreimeier","year":"2022","unstructured":"Kreimeier, S., Mott, D., Ludwig, K., Greiner, W., Group, I. H. H. (2022). Correction to: EQ-5D-Y value set for Germany. PharmacoEconomics, 40(Suppl 2), 231. https:\/\/doi.org\/10.1007\/s40273-022-01206-x","journal-title":"PharmacoEconomics"},{"issue":"2","key":"3840_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s41669-023-00443-w","volume":"8","author":"LS Matza","year":"2024","unstructured":"Matza, L. S., Howell, T. A., Fung, E. T., Janes, S. M., Seiden, M., Hackshaw, A., Nadauld, L., Karn, H., & Chung, K. C. (2024). Health state utilities associated with false-positive cancer screening results. PharmacoEconomics Open, 8(2), 263\u2013276. https:\/\/doi.org\/10.1007\/s41669-023-00443-w","journal-title":"PharmacoEconomics Open"},{"issue":"4","key":"3840_CR34","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s40273-020-00994-4","volume":"39","author":"V Prevolnik Rupel","year":"2021","unstructured":"Prevolnik Rupel, V., Ogorevc, M., Group, I. H. H. (2021). EQ-5D-Y value set for Slovenia. PharmacoEconomics, 39(4), 463\u2013471. https:\/\/doi.org\/10.1007\/s40273-020-00994-4","journal-title":"PharmacoEconomics"},{"issue":"7","key":"3840_CR35","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s40273-020-00909-3","volume":"38","author":"JM Ramos-Goni","year":"2020","unstructured":"Ramos-Goni, J. M., Oppe, M., Stolk, E., Shah, K., Kreimeier, S., Rivero-Arias, O., & Devlin, N. (2020). International valuation protocol for the EQ-5D-Y-3L. PharmacoEconomics, 38(7), 653\u2013663. https:\/\/doi.org\/10.1007\/s40273-020-00909-3","journal-title":"PharmacoEconomics"},{"issue":"3","key":"3840_CR36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s41669-021-00316-0","volume":"6","author":"TA Howell","year":"2022","unstructured":"Howell, T. A., Matza, L. S., Jun, M. P., Garcia, J., Powers, A., & Maloney, D. G. (2022). Health state utilities for adverse events associated with chimeric antigen receptor T-cell therapy in large B-cell lymphoma. PharmacoEconomics Open, 6(3), 367\u2013376. https:\/\/doi.org\/10.1007\/s41669-021-00316-0","journal-title":"PharmacoEconomics Open"},{"issue":"1","key":"3840_CR37","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s13300-019-00718-8","volume":"11","author":"LS Matza","year":"2020","unstructured":"Matza, L. S., Osumili, B., Stewart, K. D., Perez-Nieves, M., Jordan, J., Biricolti, G., Romoli, E., Losi, S., Del Santo, S., Spaepen, E., Parola, G., Karn, H., & Boye, K. S. (2020). Patient preferences and health state utilities associated with mealtime insulin concentrations among patients with diabetes in Italy. Diabetes Therapy, 11(1), 319\u2013330. https:\/\/doi.org\/10.1007\/s13300-019-00718-8","journal-title":"Diabetes Therapy"},{"issue":"3","key":"3840_CR38","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10198-019-01136-0","volume":"21","author":"LS Matza","year":"2020","unstructured":"Matza, L. S., Paramore, L. C., Stewart, K. D., Karn, H., Jobanputra, M., & Dietz, A. C. (2020). Health state utilities associated with treatment for transfusion-dependent beta-thalassemia. The European Journal of Health Economics, 21(3), 397\u2013407. https:\/\/doi.org\/10.1007\/s10198-019-01136-0","journal-title":"The European Journal of Health Economics"},{"issue":"2","key":"3840_CR39","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1177\/0194599814525576","volume":"151","author":"DJ Grindler","year":"2014","unstructured":"Grindler, D. J., Blank, S. J., Schulz, K. A., Witsell, D. L., & Lieu, J. E. (2014). Impact of otitis media severity on children\u2019s quality of life. Otolaryngology - Head and Neck Surgery, 151(2), 333\u2013340. https:\/\/doi.org\/10.1177\/0194599814525576","journal-title":"Otolaryngology - Head and Neck Surgery"},{"issue":"2","key":"3840_CR40","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1056\/NEJMoa0912254","volume":"364","author":"A Hoberman","year":"2011","unstructured":"Hoberman, A., Paradise, J. L., Rockette, H. E., Shaikh, N., Wald, E. R., Kearney, D. H., Colborn, D. K., Kurs-Lasky, M., Bhatnagar, S., Haralam, M. A., Zoffel, L. M., Jenkins, C., Pope, M. A., Balentine, T. L., & Barbadora, K. A. (2011). Treatment of acute otitis media in children under 2 years of age. New England Journal of Medicine, 364(2), 105\u2013115. https:\/\/doi.org\/10.1056\/NEJMoa0912254","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"3840_CR41","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1001\/jama.290.12.1633","volume":"290","author":"R Rothman","year":"2003","unstructured":"Rothman, R., Owens, T., & Simel, D. L. (2003). Does this child have acute otitis media? JAMA, 290(12), 1633\u20131640. https:\/\/doi.org\/10.1001\/jama.290.12.1633","journal-title":"JAMA"},{"issue":"Suppl 2","key":"3840_CR42","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1086\/596543","volume":"48","author":"SE Arifeen","year":"2009","unstructured":"Arifeen, S. E., Saha, S. K., Rahman, S., Rahman, K. M., Rahman, S. M., Bari, S., Naheed, A., Mannan, I., Seraji, M. H., Ahmed, N. U., Hassan, M. S., Huda, N., Siddik, A. U., Quasem, I., Islam, M., Fatima, K., Al-Emran, H., Brooks, W. A., Baqui, A. H., \u2026 Luby, S. P. (2009). Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance. Clinical Infectious Diseases, 48(Suppl 2), S103\u2013S113. https:\/\/doi.org\/10.1086\/596543","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"3840_CR43","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12887-018-1119-6","volume":"18","author":"MG Koliou","year":"2018","unstructured":"Koliou, M. G., Andreou, K., Lamnisos, D., Lavranos, G., Iakovides, P., Economou, C., & Soteriades, E. S. (2018). Risk factors for carriage of streptococcus pneumoniae in children. BMC Pediatrics, 18(1), 144. https:\/\/doi.org\/10.1186\/s12887-018-1119-6","journal-title":"BMC Pediatrics"},{"key":"3840_CR44","doi-asserted-by":"publisher","DOI":"10.22354\/24223794.1050","author":"S Sanchez-Marmolejo","year":"2022","unstructured":"Sanchez-Marmolejo, S., Rojas, J., Pacheco, R., Camacho-Moreno, G., Leal-Castro, A., Pati\u00f1o-Ni\u00f1o, J., Moreno, V., Guti\u00e9rrez, I., Beltr\u00e1n-H, S. J., \u00c1lvarez, M., Mari\u00f1o, A. C., Barrero, R., Espinosa, F., Arango, C., Suarez, M. A., Trujillo-H, M., Lopez-Medina, E., L\u00f3pez, P., Coronell, W., \u2026 Ramos, N. (2022). Perfil cl\u00ednico y microbiol\u00f3gico de bacteremia primaria por Streptococcus pneumoniae en pacientes pediatricos hospitalizados a la red de atenci\u00f3n terciaria Neumocolombia. 2017 \u2013 2019. Infectio. https:\/\/doi.org\/10.22354\/24223794.1050","journal-title":"Infectio"},{"key":"3840_CR45","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-3090","author":"CQ Fritz","year":"2019","unstructured":"Fritz, C. Q., Edwards, K. M., Self, W. H., Grijalva, C. G., Zhu, Y., Arnold, S. R., McCullers, J. A., Ampofo, K., Pavia, A. T., Wunderink, R. G., Anderson, E. J., Bramley, A. M., Jain, S., & Williams, D. J. (2019). Prevalence, risk factors, and outcomes of bacteremic pneumonia in children. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2018-3090","journal-title":"Pediatrics"},{"issue":"1 Pt 1","key":"3840_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.110.1.1","volume":"110","author":"TQ Tan","year":"2002","unstructured":"Tan, T. Q., Mason, E. O., Jr., Wald, E. R., Barson, W. J., Schutze, G. E., Bradley, J. S., Givner, L. B., Yogev, R., Kim, K. S., & Kaplan, S. L. (2002). Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics, 110(1 Pt 1), 1\u20136. https:\/\/doi.org\/10.1542\/peds.110.1.1","journal-title":"Pediatrics"},{"issue":"3","key":"3840_CR47","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1128\/CMR.00008-11","volume":"24","author":"BB Mook-Kanamori","year":"2011","unstructured":"Mook-Kanamori, B. B., Geldhoff, M., van der Poll, T., & van de Beek, D. (2011). Pathogenesis and pathophysiology of pneumococcal meningitis. Clinical Microbiology Reviews, 24(3), 557\u2013591. https:\/\/doi.org\/10.1128\/CMR.00008-11","journal-title":"Clinical Microbiology Reviews"},{"issue":"9375","key":"3840_CR48","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1016\/S0140-6736(03)13693-8","volume":"361","author":"X Saez-Llorens","year":"2003","unstructured":"Saez-Llorens, X., & McCracken, G. H., Jr. (2003). Bacterial meningitis in children. Lancet, 361(9375), 2139\u20132148. https:\/\/doi.org\/10.1016\/S0140-6736(03)13693-8","journal-title":"Lancet"},{"issue":"11","key":"3840_CR49","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1086\/344191","volume":"35","author":"S Esposito","year":"2002","unstructured":"Esposito, S., Bosis, S., Cavagna, R., Faelli, N., Begliatti, E., Marchisio, P., Blasi, F., Bianchi, C., & Principi, N. (2002). Characteristics of Streptococcus pneumoniae and atypical bacterial infections in children 2\u20135 years of age with community-acquired pneumonia. Clinical Infectious Diseases, 35(11), 1345\u20131352. https:\/\/doi.org\/10.1086\/344191","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"3840_CR50","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s41479-023-00109-5","volume":"15","author":"T Hu","year":"2023","unstructured":"Hu, T., Sarpong, E. M., Song, Y., Done, N., Liu, Q., Lemus-Wirtz, E., Signorovitch, J., Mohanty, S., & Weiss, T. (2023). Incidence of non-invasive all-cause pneumonia in children in the United States before and after the introduction of pneumococcal conjugate vaccines: A retrospective claims database analysis. Pneumonia (Nathan), 15(1), 8. https:\/\/doi.org\/10.1186\/s41479-023-00109-5","journal-title":"Pneumonia (Nathan)"},{"key":"3840_CR51","unstructured":"American Academy of Pediatrics. (2023). Pneumococcal Vaccines: Pneumococcal overview, AAP recommendations, and June 2023 guidance changes. Retrieved from https:\/\/www.aap.org\/en\/patient-care\/immunizations\/pneumococcal-vaccines\/#:~:text=Pneumococcal%20Overview,periorbital%20cellulitis%20and%20bacterial%20meningitis"},{"key":"3840_CR52","unstructured":"Centers for Disease Control and Prevention. (2020). Pneumococcal disease: Diagnosis and treatment. Retrieved from https:\/\/www.cdc.gov\/pneumococcal\/about\/diagnosis-treatment.html"},{"key":"3840_CR53","unstructured":"Centers for Disease Control and Prevention. (2022). Pneumococcal disease: Symptoms and complications. Retrieved from https:\/\/www.cdc.gov\/pneumococcal\/about\/symptoms-complications.html"},{"key":"3840_CR54","unstructured":"NHS Inform. (2023). Pneumococcal infections. Retrieved from https:\/\/www.nhsinform.scot\/illnesses-and-conditions\/infections-and-poisoning\/pneumococcal-infections\/#:~:text=Pneumococcal%20infections%20are%20caused%20by,more%20serious%20infection%20than%20others"},{"issue":"6","key":"3840_CR55","first-page":"350","volume":"100","author":"HL Gaddey","year":"2019","unstructured":"Gaddey, H. L., Wright, M. T., & Nelson, T. N. (2019). Otitis media: Rapid evidence review. American Family Physician, 100(6), 350\u2013356.","journal-title":"American Family Physician"},{"issue":"23","key":"3840_CR56","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1056\/NEJM199506083322307","volume":"332","author":"S Berman","year":"1995","unstructured":"Berman, S. (1995). Otitis media in children. New England Journal of Medicine, 332(23), 1560\u20131565. https:\/\/doi.org\/10.1056\/NEJM199506083322307","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"3840_CR57","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1288\/00005537-198106000-00001","volume":"91","author":"DE Gebhart","year":"1981","unstructured":"Gebhart, D. E. (1981). Tympanostomy tubes in the otitis media prone child. The Laryngoscope, 91(6), 849\u2013866. https:\/\/doi.org\/10.1288\/00005537-198106000-00001","journal-title":"The Laryngoscope"},{"issue":"12","key":"3840_CR58","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1288\/00005537-198612000-00002","volume":"96","author":"C Gonzalez","year":"1986","unstructured":"Gonzalez, C., Arnold, J. E., Woody, E. A., Erhardt, J. B., Pratt, S. R., Getts, A., Kueser, T. J., Kolmer, J. W., & Sachs, M. (1986). Prevention of recurrent acute otitis media: chemoprophylaxis versus tympanostomy tubes. The Laryngoscope, 96(12), 1330\u20131334.","journal-title":"The Laryngoscope"},{"key":"3840_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004741.pub2","author":"S McDonald","year":"2008","unstructured":"McDonald, S., Langton Hewer, C. D., & Nunez, D. A. (2008). Grommets (ventilation tubes) for recurrent acute otitis media in children. Cochrane Database of Systematic Reviews. https:\/\/doi.org\/10.1002\/14651858.CD004741.pub2","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1_suppl","key":"3840_CR60","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1177\/01945998211065662","volume":"166","author":"RM Rosenfeld","year":"2022","unstructured":"Rosenfeld, R. M., Tunkel, D. E., Schwartz, S. R., Anne, S., Bishop, C. E., Chelius, D. C., Hackell, J., Hunter, L. L., Keppel, K. L., Kim, A. H., Kim, T. W., Levine, J. M., Maksimoski, M. T., Moore, D. J., Preciado, D. A., Raol, N. P., Vaughan, W. K., Walker, E. A., & Monjur, T. M. (2022). Clinical practice guideline: Tympanostomy tubes in children (Update). Otolaryngology-Head and Neck Surgery, 166(1_suppl), S1\u2013S55. https:\/\/doi.org\/10.1177\/01945998211065662","journal-title":"Otolaryngology-Head and Neck Surgery"},{"issue":"1","key":"3840_CR61","doi-asserted-by":"publisher","first-page":"16063","DOI":"10.1038\/nrdp.2016.63","volume":"2","author":"AG Schilder","year":"2016","unstructured":"Schilder, A. G., Chonmaitree, T., Cripps, A. W., Rosenfeld, R. M., Casselbrant, M. L., Haggard, M. P., & Venekamp, R. P. (2016). Otitis media. Nature Reviews Disease Primers, 2(1), 16063. https:\/\/doi.org\/10.1038\/nrdp.2016.63","journal-title":"Nature Reviews Disease Primers"},{"issue":"19","key":"3840_CR62","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1056\/NEJMoa2027278","volume":"384","author":"A Hoberman","year":"2021","unstructured":"Hoberman, A., Preciado, D., Paradise, J. L., Chi, D. H., Haralam, M., Block, S. L., Kearney, D. H., Bhatnagar, S., Muniz Pujalt, G. B., Shope, T. R., Martin, J. M., Felten, D. E., Kurs-Lasky, M., Liu, H., Yahner, K., Jeong, J. H., Cohen, N. L., Czervionke, B., Nagg, J. P., \u2026 Shaikh, N. (2021). Tympanostomy tubes or medical management for recurrent acute otitis media. New England Journal of Medicine, 384(19), 1789\u20131799. https:\/\/doi.org\/10.1056\/NEJMoa2027278","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"3840_CR63","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11136-010-9605-9","volume":"19","author":"AE Attema","year":"2010","unstructured":"Attema, A. E., & Brouwer, W. B. (2010). On the (not so) constant proportional trade-off in TTO. Quality of Life Research, 19(4), 489\u2013497. https:\/\/doi.org\/10.1007\/s11136-010-9605-9","journal-title":"Quality of Life Research"},{"issue":"8","key":"3840_CR64","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s10198-015-0740-7","volume":"17","author":"LS Matza","year":"2016","unstructured":"Matza, L. S., Boye, K. S., Feeny, D. H., Bowman, L., Johnston, J. A., Stewart, K. D., McDaniel, K., & Jordan, J. (2016). The time horizon matters: Results of an exploratory study varying the timeframe in time trade-off and standard gamble utility elicitation. The European Journal of Health Economics, 17(8), 979\u2013990. https:\/\/doi.org\/10.1007\/s10198-015-0740-7","journal-title":"The European Journal of Health Economics"},{"issue":"5","key":"3840_CR65","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/hec.2819","volume":"22","author":"N Devlin","year":"2013","unstructured":"Devlin, N., Buckingham, K., Shah, K., Tsuchiya, A., Tilling, C., Wilkinson, G., & van Hout, B. (2013). A comparison of alternative variants of the lead and lag time TTO. Health Economics, 22(5), 517\u2013532. https:\/\/doi.org\/10.1002\/hec.2819","journal-title":"Health Economics"},{"issue":"5","key":"3840_CR66","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1177\/0272989X09357475","volume":"30","author":"C Tilling","year":"2010","unstructured":"Tilling, C., Devlin, N., Tsuchiya, A., & Buckingham, K. (2010). Protocols for time tradeoff valuations of health states worse than dead: A literature review. Medical Decision Making, 30(5), 610\u2013619. https:\/\/doi.org\/10.1177\/0272989X09357475","journal-title":"Medical Decision Making"},{"issue":"12","key":"3840_CR67","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1002\/hec.2894","volume":"22","author":"AE Attema","year":"2013","unstructured":"Attema, A. E., & Versteegh, M. M. (2013). Would you rather be ill now, or later? Health Economics, 22(12), 1496\u20131506. https:\/\/doi.org\/10.1002\/hec.2894","journal-title":"Health Economics"},{"issue":"Suppl 1","key":"3840_CR68","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1007\/s10198-013-0507-y","volume":"14","author":"MM Versteegh","year":"2013","unstructured":"Versteegh, M. M., Attema, A. E., Oppe, M., Devlin, N. J., & Stolk, E. A. (2013). Time to tweak the TTO: results from a comparison of alternative specifications of the TTO. The European Journal of Health Economics, 14(Suppl 1), S43\u2013S51. https:\/\/doi.org\/10.1007\/s10198-013-0507-y","journal-title":"The European Journal of Health Economics"},{"issue":"3\u20134","key":"3840_CR69","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3233\/PRM-170453","volume":"10","author":"R Jiang","year":"2017","unstructured":"Jiang, R., Inouye, B. M., Wang, H. S., Tejwani, R., & Routh, J. C. (2017). Crowdsourcing utility estimation for spina bifida in the general population. J Pediatr Rehabil Med, 10(3\u20134), 257\u2013266. https:\/\/doi.org\/10.3233\/PRM-170453","journal-title":"J Pediatr Rehabil Med"},{"issue":"2","key":"3840_CR70","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3171\/2017.2.PEDS16567","volume":"20","author":"V Kuta","year":"2017","unstructured":"Kuta, V., McNeely, P. D., Walling, S., & Bezuhly, M. (2017). Sagittal craniosynostosis: A utility outcomes study. Journal of Neurosurgery Pediatrics, 20(2), 113\u2013118. https:\/\/doi.org\/10.3171\/2017.2.PEDS16567","journal-title":"Journal of Neurosurgery Pediatrics"},{"issue":"2","key":"3840_CR71","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1365-2133.2005.06736.x","volume":"153","author":"KJ Stevens","year":"2005","unstructured":"Stevens, K. J., Brazier, J. E., McKenna, S. P., Doward, L. C., & Cork, M. J. (2005). The development of a preference-based measure of health in children with atopic dermatitis. British Journal of Dermatology, 153(2), 372\u2013377. https:\/\/doi.org\/10.1111\/j.1365-2133.2005.06736.x","journal-title":"British Journal of Dermatology"},{"issue":"7","key":"3840_CR72","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/00005650-199607000-00004","volume":"34","author":"GW Torrance","year":"1996","unstructured":"Torrance, G. W., Feeny, D. H., Furlong, W. J., Barr, R. D., Zhang, Y., & Wang, Q. (1996). Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. Medical Care, 34(7), 702\u2013722. https:\/\/doi.org\/10.1097\/00005650-199607000-00004","journal-title":"Medical Care"},{"issue":"1","key":"3840_CR73","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jval.2010.10.026","volume":"14","author":"LA Prosser","year":"2011","unstructured":"Prosser, L. A., Payne, K., Rusinak, D., Shi, P., Uyeki, T., & Messonnier, M. (2011). Valuing health across the lifespan: Health state preferences for seasonal influenza illnesses in patients of different ages. Value in Health, 14(1), 135\u2013143. https:\/\/doi.org\/10.1016\/j.jval.2010.10.026","journal-title":"Value in Health"},{"issue":"5 Suppl 1","key":"3840_CR74","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1016\/j.jval.2011.05.007","volume":"14","author":"J Galante","year":"2011","unstructured":"Galante, J., Augustovski, F., Colantonio, L., Bardach, A., Caporale, J., Marti, S. G., & Kind, P. (2011). Estimation and comparison of EQ-5D health states\u2019 utility weights for pneumococcal and human papillomavirus diseases in Argentina, Chile, and the United Kingdom. Value in Health, 14(5 Suppl 1), S60\u2013S64. https:\/\/doi.org\/10.1016\/j.jval.2011.05.007","journal-title":"Value in Health"},{"issue":"2","key":"3840_CR75","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/00006454-200002000-00010","volume":"19","author":"M Kuppermann","year":"2000","unstructured":"Kuppermann, M., Nease, R. F., Jr., Ackerson, L. M., Black, S. B., Shinefield, H. R., & Lieu, T. A. (2000). Parents\u2019 preferences for outcomes associated with childhood vaccinations. The Pediatric Infectious Disease Journal, 19(2), 129\u2013133. https:\/\/doi.org\/10.1097\/00006454-200002000-00010","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"4","key":"3840_CR76","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s40273-019-00783-8","volume":"37","author":"TA Lavelle","year":"2019","unstructured":"Lavelle, T. A., Weinstein, M. C., Newhouse, J. P., Munir, K., Kuhlthau, K. A., & Prosser, L. A. (2019). Parent preferences for health outcomes associated with autism spectrum disorders. PharmacoEconomics, 37(4), 541\u2013551. https:\/\/doi.org\/10.1007\/s40273-019-00783-8","journal-title":"PharmacoEconomics"},{"issue":"1","key":"3840_CR77","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s41687-020-00276-9","volume":"5","author":"B Nafees","year":"2021","unstructured":"Nafees, B., Lloyd, A., & Dewilde, S. (2021). Estimating health state utilities in hemophagocytic lymphohistiocytosis. Journal of Patient-Reported Outcomes, 5(1), 12. https:\/\/doi.org\/10.1186\/s41687-020-00276-9","journal-title":"Journal of Patient-Reported Outcomes"},{"key":"3840_CR78","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.vhri.2019.01.003","volume":"18","author":"S Shahjouei","year":"2019","unstructured":"Shahjouei, S., Vafaei Sadr, A., Khorasani, S., Nejat, F., Habibi, Z., & Akbari Sari, A. (2019). Utility measures in pediatric temporary health states: Comparison of prone positioning valuation through 5 assessment tools. Value in Health Regional Issues, 18, 97\u2013105. https:\/\/doi.org\/10.1016\/j.vhri.2019.01.003","journal-title":"Value in Health Regional Issues"},{"issue":"1","key":"3840_CR79","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10198-012-0443-2","volume":"15","author":"LS Matza","year":"2014","unstructured":"Matza, L. S., Chung, K., Van Brunt, K., Brazier, J. E., Braun, A., Currie, B., Palsgrove, A., Davies, E., & Body, J. J. (2014). Health state utilities for skeletal-related events secondary to bone metastases. The European Journal of Health Economics, 15(1), 7\u201318. https:\/\/doi.org\/10.1007\/s10198-012-0443-2","journal-title":"The European Journal of Health Economics"},{"issue":"9","key":"3840_CR80","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1080\/13696998.2020.1776719","volume":"23","author":"LS Matza","year":"2020","unstructured":"Matza, L. S., Phillips, G. A., Howell, T. A., Ciffone, N., & Ahmad, Z. (2020). Estimating health state utilities associated with a rare disease: Familial chylomicronemia syndrome (FCS). Journal of Medical Economics, 23(9), 978\u2013984. https:\/\/doi.org\/10.1080\/13696998.2020.1776719","journal-title":"Journal of Medical Economics"},{"issue":"2","key":"3840_CR81","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1542\/peds.2004-0778","volume":"115","author":"CN Brouwer","year":"2005","unstructured":"Brouwer, C. N., Maille, A. R., Rovers, M. M., Veenhoven, R. H., Grobbee, D. E., Sanders, E. A., & Schilder, A. G. (2005). Effect of pneumococcal vaccination on quality of life in children with recurrent acute otitis media: A randomized, controlled trial. Pediatrics, 115(2), 273\u2013279. https:\/\/doi.org\/10.1542\/peds.2004-0778","journal-title":"Pediatrics"},{"key":"3840_CR82","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/1477-7525-11-201","volume":"11","author":"CH Heidemann","year":"2013","unstructured":"Heidemann, C. H., Godballe, C., Kjeldsen, A. D., Johansen, E. C., Faber, C. E., & Lauridsen, H. H. (2013). The Otitis Media-6 questionnaire: Psychometric properties with emphasis on factor structure and interpretability. Health and Quality of Life Outcomes, 11, 201. https:\/\/doi.org\/10.1186\/1477-7525-11-201","journal-title":"Health and Quality of Life Outcomes"},{"issue":"7","key":"3840_CR83","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/INF.0000000000000265","volume":"33","author":"T Kujala","year":"2014","unstructured":"Kujala, T., Alho, O. P., Kristo, A., Uhari, M., Renko, M., Pokka, T., & Koivunen, P. (2014). Quality of life after surgery for recurrent otitis media in a randomized controlled trial. The Pediatric Infectious Disease Journal, 33(7), 715\u2013719. https:\/\/doi.org\/10.1097\/INF.0000000000000265","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"2","key":"3840_CR84","doi-asserted-by":"publisher","first-page":"e31239","DOI":"10.1371\/journal.pone.0031239","volume":"7","author":"K Edmond","year":"2012","unstructured":"Edmond, K., Scott, S., Korczak, V., Ward, C., Sanderson, C., Theodoratou, E., Clark, A., Griffiths, U., Rudan, I., & Campbell, H. (2012). Long term sequelae from childhood pneumonia; systematic review and meta-analysis. PLoS ONE, 7(2), e31239. https:\/\/doi.org\/10.1371\/journal.pone.0031239","journal-title":"PLoS ONE"},{"issue":"1","key":"3840_CR85","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41479-023-00110-y","volume":"15","author":"KL Kruckow","year":"2023","unstructured":"Kruckow, K. L., Zhao, K., Bowdish, D. M. E., & Orihuela, C. J. (2023). Acute organ injury and long-term sequelae of severe pneumococcal infections. Pneumonia (Nathan), 15(1), 5. https:\/\/doi.org\/10.1186\/s41479-023-00110-y","journal-title":"Pneumonia (Nathan)"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-024-03840-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-024-03840-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-024-03840-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:43:23Z","timestamp":1742345003000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11136-024-03840-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["3840"],"URL":"https:\/\/doi.org\/10.1007\/s11136-024-03840-8","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,3]]},"assertion":[{"value":"7 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LM, TH, and LH are employed by Evidera, which received funding support from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co. Inc., Rahway, NJ, USA to conduct this research. BC, MW, TW, MH, KF, and SM are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, and may own stock and\/or hold stock options in Merck & Co., Inc., Rahway, NJ, USA. DR consulted on the pediatric utility methodology and received funding for time spent on this consultation. MK, BN, and AH receive consulting fees and grant funding from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol and all study materials were approved by the Salus Institutional Review Board (study 22451), and all participants provided informed consent before participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}